Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe site revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This update is a metadata release tag and does not change study data or content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew help/navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label has been updated. The study's recruitment status is now shown as 'No longer looking for participants,' and a new revision entry 'Revision: v3.6.0' has been introduced.SummaryDifference0.5%

- Check29 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, reflecting an update to the page's metadata.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows a revised version number (v3.5.4) replacing v3.5.3, indicating a deployment or patch without altering the displayed study information.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page footer updates the ClinicalTrials.gov release “Revision” number from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.